Cures & Capital
Hello and welcome to Cures & Capital - the podcast on value creation in biotech and pharma.
Together, we are going to dive deep into the world of biotech and pharma to tackle the holy grail - how do we improve return on investment from drug innovation and deliver transformative therapies to patients, efficiently and sustainably.
Hosted by Martin Slezak & Simon Birksø
Disclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.
Cures & Capital
Mike Rea on why pharma struggles with innovation - and how to fix it
In this episode, Mike Rea - CEO, IDEA Pharma - takes us on a journey through innovation and value creation in pharma. It is not all roses!
He shares his candid views on what the pharmaceutical industry needs to do better to be less confused about innovation.
Mike Rea also explains the importance of getting the definition of innovation right in drug development. Early commercial involvement in drug R&D is another key pillar in his drug innovation philosophy.
We also get to discuss organizational design and team size conducive to unlocking pharma's innovation potential.
You can easily get in touch with Mike Rea through LinkedIn, X, etc.
If you want to connect with us - and join the discussions with other listeners:
Linkedin: https://www.linkedin.com/company/cures-capital-podcast
YouTube - watch the interview:
https://www.youtube.com/@CuresCapital
Disclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.
